$XRAY

PDS Health Surpasses Five Million CEREC Chairside Restorations with Dentsply Sirona, Marking a Major Milestone in Scaled Digital Dentistry

PDS Health and Dentsply Sirona said PDS Health practices have completed over 5 million CEREC chairside restorations. The companies cite 1,200+ CEREC systems installed across PDS Health practices and ongoing collaboration to support digital CAD/CAM workflows and same-day restorative care. Dentsply Sirona’s shares trade on Nasdaq as XRAY.

Original reporting
Published Jul 1, 2026, 9:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 10:08 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
PDS Health Surpasses Five Million CEREC Chairside Restorations with Dentsply Sirona, Marking a Major Milestone in Scaled Digital Dentistry — source image
Decision brief

The 30-second read

$XRAYBullishLow
01

Why it matters

The milestone highlights sustained clinician adoption (1,200+ CEREC systems installed across PDS Health practices) and same-day restorative capabilities, but the release does not quantify financial impact or announce new commercial terms.

02

Market read

Primarily a digital dentistry adoption proof-point; useful for narrative/positioning but not a clear catalyst for earnings or guidance.

03

What to watch

Traders may be over-weighting installed-base milestones; the key missing items are pricing, service attach rates, renewal/upgrade cadence, and any new commercial agreement.

Relevance 4/10Novelty 4/10Timing: today’s PR/milestone announcement

Background

PDS Health and Dentsply Sirona have a long-standing collaboration around CEREC chairside CAD/CAM workflows.

Company-level read

Ticker impact

$XRAYBullishLow confidence
Context

Dentsply Sirona is named as the collaboration partner as PDS Health surpasses five million CEREC chairside restorations.

Expected impact

Likely limited near-term impact; could support longer-term sentiment around CEREC installed base and adoption.

Evidence & confidence

This is a promotional milestone without incremental revenue, contract terms, or forward-looking targets; any read-through is indirect.

Market effects

Reinforces the digital dentistry/CAD-CAM adoption narrative, potentially supportive for dental equipment and workflow software sentiment.

No specific regional demand or regulatory angle disclosed.

No global expansion or international contract details provided; impact is primarily adoption proof-point.

Counterpoint

A chairside restoration count is not the same as incremental revenue; without commercial terms, it may not change XRAY’s near-term fundamentals.

Key entities

  • PDS Health

    Dental practice operator highlighted as surpassing five million CEREC chairside restorations.

  • Dentsply Sirona

    CEREC technology provider; collaboration partner named and identified as XRAY on Nasdaq.

  • CEREC

    Chairside CAD/CAM restorative workflow referenced as the basis for the restoration milestone.

Related articles

$XRAYMedAI 8/10

Why Dentsply Sirona (XRAY) Stock Is Trading Lower Today

Dentsply Sirona (XRAY) shares fell about 7% after the company reported Q2 2026 results. Revenue declined 4.1% to $898 million and topped expectations, while adjusted EPS of $0.52 beat estimates. The stock dropped on a weaker full-year revenue forecast of $3.55 billion at the midpoint, about 1% below consensus.

$XRAYMedAI 8/10

XRAY Stock Falls Despite Q2 Earnings Beat, Wellspect Drives Sales

Dentsply Sirona (XRAY) reported Q2 2026 adjusted EPS of 52 cents, down 1.6% YoY but above the Zacks Consensus estimate of 36 cents. Revenue fell 4.1% to $898 million. Wellspect Healthcare growth helped offset declines in other dental segments. The company kept 2026 net sales guidance at $3.5B-$3.6B and adjusted EPS at $1.40-$1.50.

SK hynix to Invest 54 Trillion Won, Weighs Sale of China Chongqing Plant

SK hynix said its board approved total investment of about 54.3 trillion won to build DRAM fab “Y2” in Yongin (35.2 trillion won) and NAND fab “M17” in Cheongju (19.1 trillion won), targeting next-generation DRAM/HBM and NAND capacity. It is also reportedly reviewing options to sell its stake in a Chongqing packaging plant, with enterprise value forecast near $3 billion, per Bloomberg.